Pages that link to "Q44653587"
Jump to navigation
Jump to search
The following pages link to Enhanced Adenovirus Infection of Melanoma Cells by Fiber-Modification: Incorporation of RGD Peptide or Ad5/3 Chimerism (Q44653587):
Displayed 37 items.
- Circumventing antivector immunity: potential use of nonhuman adenoviral vectors (Q26995655) (← links)
- Novel system uses probasin-based promoter, transcriptional silencers and amplification loop to induce high-level prostate expression (Q33273469) (← links)
- Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses (Q33425253) (← links)
- Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF. (Q34183436) (← links)
- Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma (Q34426949) (← links)
- Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism (Q34667746) (← links)
- Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes (Q35142325) (← links)
- Gene Therapies for Cancer: Strategies, Challenges and Successes (Q35186312) (← links)
- Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells (Q35587169) (← links)
- mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine (Q35609031) (← links)
- Highly specific transgene expression mediated by a complex adenovirus vector incorporating a prostate-specific amplification feedback loop (Q35695549) (← links)
- Tissue-specific promoters for cancer gene therapy (Q35779378) (← links)
- A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents (Q35874291) (← links)
- Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism (Q36468656) (← links)
- Targeting adenoviral vectors for enhanced gene therapy of uterine leiomyomas (Q37109089) (← links)
- Tropism-modification strategies for targeted gene delivery using adenoviral vectors (Q38614156) (← links)
- Novel oncolytic viral therapies in patients with thoracic malignancies (Q39067827) (← links)
- Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid. (Q39410097) (← links)
- Oncolytic adenovirus based on serotype 3. (Q39616158) (← links)
- Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells (Q39740442) (← links)
- Defining the role of CD46, CD80 and CD86 in mediating adenovirus type 3 fiber interactions with host cells. (Q39812421) (← links)
- E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies (Q39864968) (← links)
- Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells (Q39948164) (← links)
- Combining adenoviral oncolysis with temozolomide improves cell killing of melanoma cells (Q40088612) (← links)
- Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domain (Q40189728) (← links)
- Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer. (Q40264235) (← links)
- Infectivity enhancement for adenoviral transduction of canine osteosarcoma cells (Q40350503) (← links)
- Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors. (Q40459504) (← links)
- Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathways (Q40514543) (← links)
- Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells (Q45117334) (← links)
- Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses (Q45856180) (← links)
- Cancer Terminator Viruses (CTV): A Better Solution for Viral-Based Therapy of Cancer. (Q47560447) (← links)
- Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX (Q59354245) (← links)
- Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses (Q64245487) (← links)
- Engineering protein nanocages as carriers for biomedical applications (Q90698268) (← links)
- Unravelling Receptor and RGD Motif Dependence of Retargeted Adenoviral Vectors using Advanced Tumor Model Systems (Q91768182) (← links)
- CRISPR-Cas12a with an oAd Induces Precise and Cancer-Specific Genomic Reprogramming of EGFR and Efficient Tumor Regression (Q97589304) (← links)